Business - Briefly   

Orchid in R&D pact with Pfizer

MUMBAI: Orchid Chemicals & Pharmaceuticals on Thursday said it had signed a long-term master research and development agreement with Pfizer International, LLC. Orchid Chemicals informed the stock exchanges that it would provide research and development services to Pfizer's animal health business as per the agreement, which is for a period of seven years and renewable thereafter.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Indian Iron and Steel merges with SAIL
`No review of power tariff policy for now'
Sensex touches new intra-day peak
SpiceJet gets its own aircraft
Fenner plans greenfield projects
`IT players must aim to thrive, not just survive'
IBM opens HiPODS lab
SEBI curbs on erring firms
Rupee declines further
Exchange rates
Bullion rates
Ranbaxy raises $400 m through FCCBs
Orchid in R&D pact with Pfizer
Dr. Reddy's to acquire Betapharm
Permal launches India fund of hedge funds
PERT opens Q&A box on Union Budget
Prudential ICICI launches Fusion Fund
Henkel India registers all round growth
South Indian Bank fixes cut-off price at Rs. 66
New corporate identity for MBT
Workshop on fashion knowhow

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu